BIOMAT Database Logo BIOMAT Database Logo

Adrenergic neuron blocking properties of (plus or minus)-propranolol and (plus)-propranolol. 1970

A M Barrett, and B Nunn

UI MeSH Term Description Entries
D001949 Bretylium Compounds Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE. Compounds, Bretylium
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001158 Arteries The vessels carrying blood away from the heart. Artery

Related Publications

A M Barrett, and B Nunn
The adrenergic neuron blocking activity of propranolol and alprenolol.
August 1975, Archivos de farmacologia y toxicologia,
A M Barrett, and B Nunn
Mechanism of adrenergic neuron blocking effects of propranolol & pronethalol.
March 1973, Indian journal of experimental biology,
A M Barrett, and B Nunn
Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
August 1970, British journal of pharmacology,
A M Barrett, and B Nunn
An adrenergic neuron blocking action of propranolol in isolated tissues.
December 1968, The Journal of pharmacy and pharmacology,
A M Barrett, and B Nunn
Effect of (plus or minus) dihydroxy ephedrine and (plus or minus) dihydroxy pseudoephedrine on adrenergic transmission in mesenteric arteries.
February 1971, British journal of pharmacology,
A M Barrett, and B Nunn
A comparison of the effects of (plus of minus)-propranolol and (plus)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action.
April 1969, The Journal of pharmacy and pharmacology,
A M Barrett, and B Nunn
Assessment of -adrenergic blocking and non-specific properties of propranolol.
July 1971, British heart journal,
A M Barrett, and B Nunn
Studies on the syntheses of heterocyclic compounds. CDLXII. Total photolytic syntheses of aporphine ((plus or minus)-N-methyl-laurotetanine, (plus or minus)-cassythicine, and (plus or minus)-pukateine), proaporphine ((plus or minus)-orientalinone), and morphinandienone ((plus or minus)-pallidine and (plus or minus)-salutaridine) alkaloids.
January 1972, Journal of the Chemical Society. Perkin transactions 1,
A M Barrett, and B Nunn
Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.
November 1973, Journal of medicinal chemistry,
A M Barrett, and B Nunn
Beta-adrenergic blocking effects of propranolol.
December 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!